PYXS
Pyxis Oncology Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.54
+0.01 ▲ +0.65%
🌙 3월 13일 7:50 PM ET (한국 3/14 08:50)
$1.50
-0.04 ▼ -2.58%
| Index | - | P/E | - | EPS (ttm) | -1.59 | Insider Own | 22.76% | Shs Outstand | 0.06B | Perf Week | 12.41% |
| Market Cap | 0.10B | Forward P/E | - | EPS next Y | 9.42% | Insider Trans | - | Shs Float | 0.05B | Perf Month | 14.07% |
| Enterprise Value | 0.04B | PEG | - | EPS next Q | -0.34 | Inst Own | 37.19% | Short Float | 5.25% | Perf Quarter | -64.1% |
| Income | -0.10B | P/S | 34 | EPS this Y | -1.08% | Inst Trans | -3.83% | Short Ratio | 2.16 | Perf Half Y | -17.2% |
| Sales | 0.00B | P/B | 1.39 | EPS next 5Y | -0.91% | ROA | -64.53% | Short Interest | 2.53M | Perf YTD | 33.91% |
| Book/sh | 1.11 | P/C | 1.23 | EPS past 3/5Y | 17.52% -74.92% | ROE | -87.28% | 52W High | -72.25% ($5.55) | Perf Year | 43.93% |
| Cash/sh | 1.25 | P/FCF | - | Sales past 3/5Y | - | ROIC | -112.6% | 52W Low | 84.83% ($0.83) | Perf 3Y | -23% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -52% | Gross Margin | 23.26% | Volatility(W/M) | 8.18% 7.15% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | 13.2 | Sales Y/Y TTM | -82.53% | Oper. Margin | -3022.34% | ATR (14) | 0.12 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 4.29 | EPS Q/Q | -0.72% | Profit Margin | -3442.77% | RSI (14) | 51.48 | Recom | 1.22 |
| Dividend Gr. 3/5Y | - | Current Ratio | 4.29 | Sales Q/Q | - | SMA20 | 5.55% ($1.46) | Beta | 1.43 | Target Price | $6.92 |
| Payout | - | Debt/Eq | 0.28 | Earnings | 11000000 | SMA50 | 1.82% ($1.51) | Rel Volume | 0.2 | Prev Close | $1.53 |
| Employees | 44 | LT Debt/Eq | 0.25 | EPS/Sales Surpr. | -4.79% - | SMA200 | -26.79% ($2.1) | Avg Volume(3M) | 1.17M | Price | $1.54 |
| IPO | 2021/10/8 | Option/Short | Yes/Yes | Trades | 1272 | Volume | 228,523 | Change | 0.65% |
뉴스 로딩 중...